Published date: 22 November 2024
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Health services - 85100000
Location of contract
SW1H 0EU
Value of contract
£127,400 to £152,880
Procurement reference
CF-2699900D0O000000rwimUAA
Published date
22 November 2024
Closing date
11 November 2024
Closing time
12pm
Contract start date
1 December 2024
Contract end date
31 July 2025
Contract type
Service contract
Procedure type
Single tender action (below threshold)
A direct contract with a single supplier, without competition.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The second phase of work on the prostate cancer cost-effectiveness model will build on the initial efforts update a suitable prostate cancer cost effectiveness model, focusing on further evaluation and development of the model to influence screening programmes.
To evaluate the cost-effectiveness of PSA-based screening for all men aged 45-70- and 45-75-year-old, with the frequency of testing stratified by individual risk calculated from an initial PSA, age, ethnicity, and family history (e.g., initially yearly for high-risk and 3-5 yearly for low-risk men).
To evaluate the cost-effectiveness of prostate cancer screening programmes for men between the age of 50-69 years with a Charlson Comorbidity Index (≤3) using the Stockholm3 blood test.
The delivery will also explore:
• a screening programme for prostate cancer for men aged 45-70 who have a first-degree rela-tive diagnosed with prostate, breast or ovarian cancer (relevant family history)
• a screening programme in black men aged 45 - 70
• a screening programme in BRCA2 carriers
The prostate cancer screening model developed and owned by the University of Sheffield was deemed the most independent and suitable option for achieving the project's deliverables.
Contract value: £127,400 exclusive of VAT. £152,880 inclusive of VAT
Term: 7 months up to 31/072025 with the option to extend for up to 6 months to the discretion of the authority.
More information
Attachments
-
- C319115_Prostate Cancer Model Phase 2_REDACTED.pdf
- C319115_Prostate Cancer Model Phase 2_REDACTED
Award information
Awarded date
22 November 2024
Contract start date
1 December 2024
Contract end date
31 July 2025
Total value of contract
£152,880
This contract was awarded to 1 supplier.
THE UNIVERSITY OF SHEFFIELD
Address
Regent Court, Regent street S14DA
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Julia Estruga
Address
Victoria Road
London
SW1H 0EU
GB
Telephone
01132045540
Share this notice
Closing: 11 November 2024, 12pm